Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-10-21Clinical Trial Update: Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients [Phase 3]
This update describes a Phase 3 clinical trial evaluating systemic chemotherapy combined with recombinant human adenovirus type 5 and endost…
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer [Phase 2]
This document reports a completed Phase 2 trial evaluating FDG-labeled PET scans to guide chemotherapy planning in patients with stage IIIB …
-
CLINICAL_TRIALS trial_result · 2016-10-21Clinical Trial Update: 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study [Phase 3]
A multicenter Phase 3 clinical trial assessing whether 18F-FDG PET imaging can monitor the effectiveness of chemotherapy in non-small cell l…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation [Phase 2]
Phase 2 trial evaluating erlotinib as adjuvant therapy after surgery in patients with EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy [Phase 2]
Phase 2 study evaluating MK-2206 with erlotinib in advanced non-small cell lung cancer patients who progressed after prior erlotinib; the tr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival [NA]
Completed clinical trial assessing whether FDG-TEP during radiotherapy or chemoradiotherapy can predict one-year survival in non-small cell …
-
CLINICAL_TRIALS research · 2016-10-13Clinical Trial Update: Gefitinib Combined With Chemotherapy or Antiangiogensis in Patients With Bim Deletion or Low EGFR Mutation Abundance [Phase 2]
Phase 2 study assessing gefitinib in combination with chemotherapy or antiangiogenic therapy in non-small-cell lung cancer patients with BIM…
-
CLINICAL_TRIALS withdrawal · 2016-10-12Clinical Trial Update: Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating pazopanib in combination with paclitaxel for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: AZD9291 First Time In Patients Ascending Dose Study [Phase 1, Phase 2]
Phase 1/2 ascending-dose study of AZD9291 (osimertinib) in advanced non-small cell lung cancer completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Common Safety Follow-up Trial of Tecemotide (L-BLP25) [NA]
The common safety follow-up trial of Tecemotide (L-BLP25) was terminated, with results posted on 2016-10-06.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab [Phase 4]
Open-label Phase 4 trial in metastatic non-small cell lung cancer assessing cisplatin, gemcitabine, and bevacizumab; study status is complet…
-
FDA label_change · 2016-10-04FDA Approved: GILOTRIF — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Gilotrif (afatinib) submitted by Boehringer Ingelheim, updating labeling for the drug.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer [Phase 2]
This report updates results from a Phase 2 trial evaluating paclitaxel, carboplatin, and bevacizumab in patients with pretreated, advanced o…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Metronomic Vinorelbine and Bevacizumab in Patients With Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial of metronomic vinorelbine with bevacizumab in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer [Phase 3]
This document reports a Phase 3 clinical trial update from Pierre Fabre Medicament evaluating an oral chemotherapy and platinum-based regime…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Pemetrexed Plus Bevacizumab in Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating pemetrexed plus bevacizumab in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 4]
This clinical trial update reports the results from an expanded access program of Tarceva (erlotinib) in participants with advanced non-smal…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Docetaxel Plus Bevacizumab in Metastatic Non Small Cell Lung Cancer [Phase 2]
A Phase 2 study of docetaxel plus bevacizumab for metastatic non-small cell lung cancer has been completed in a trial sponsored by the Helle…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers [Phase 1]
Phase 1, single-dose pilot study evaluating radiolabeled amatuximab (MORAb-009) in mesothelin-overexpressing cancers has completed. The stud…
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Metformin in Stage IV Lung Adenocarcinoma [Phase 2]
A Phase 2 trial of metformin in stage IV non-small cell lung cancer (lung adenocarcinoma) has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors [Phase 1]
A Phase 1 study of DKN-01 in multiple myeloma or advanced solid tumors has completed enrollment with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC [Phase 1]
Phase 1 study assessing the effect of rifampicin on blood levels and safety of AZD9291 in patients with EGFRm+ non-small cell lung cancer ha…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating an autologous tumor DRibble vaccine in patients with Non-Small Cell Lung Cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection [Phase 1]
A multicenter Phase I study of MRX34 liposomal injection (miR-34a mimic) across several cancers has been terminated.
-
CLINICAL_TRIALS research · 2016-09-27Clinical Trial Update: Neoadjuvant Concurrent Chemoradiation With Weekly Docetaxel/Cisplatin for Resectable IIIA-N2 NSCLC [Phase 2]
This document provides a Phase 2 trial update on neoadjuvant concurrent chemoradiation with weekly docetaxel and cisplatin for resectable II…